Personalized Tactile Cueing for Parkinson's Disease

Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Oregon Health and Science University · Other
Who this trial is looking for

This trial is looking for people with Parkinson's disease to test a new cueing system that may help improve walking. Participants will be assigned to one of two groups to see how the cueing affects their walking ability.

Are You a Good Fit for This Trial?
Must not be taking Dopamine-blocking agentsCholinesterase inhibitors
Rules you out Progressive supranuclear palsyMultiple system atrophyCorticobasal syndromeVascular parkinsonism

You may be able to join if

  • I have been diagnosed with Parkinson's disease.
  • I can follow directions for the study.
  • I can give my consent to participate.
  • I have mild to moderate symptoms (Hoehn & Yahr Levels II-III).

You may not be able to join if

  • I have severe movement issues that could affect study results.
  • I have a major medical condition affecting walking.
  • My cognitive assessment score is below 21.
  • I cannot stand or walk for 2 minutes without help.
  • I have Parkinson's plus syndromes or implanted electrodes.
  • I currently take medications that can affect my walking.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of the study is to determine the effects of a novel, personalized, tactile cueing system on gait automaticity. The researchers hypothesized that step-synchronized tactile cueing will reduce prefrontal cortex activity (improve automaticity) and improve gait variability (as well as gait speed). The researchers predict that improved automaticity with improved gait variability will be asso…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of idiopathic Parkinson's Disease from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia with 1 or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive c…
Contacts

Francesa Alcalá, B.S.

503-913-3691

alcalaf@ohsu.edu

CONTACT

Graham Harker, MPH

503-418-2601

harkerh@ohsu.edu

CONTACT